Osteogenesis imprefecta and type‐I collagen mutations
- 1 February 1993
- journal article
- Published by Wiley in European Journal of Biochemistry
- Vol. 211 (3) , 415-419
- https://doi.org/10.1111/j.1432-1033.1993.tb17565.x
Abstract
In this study we describe a new dominant point mutation in COL1A1 causing a lethal form of Osteogenesis imperfecta (type II B). Dermal cultured fibroblasts from the proband were shown to produce both normal and hevily overmodified type‐I collagen. The mutation introduced a local conformational perturbation, which causes abonormal exposure of arginine residues; the triple helical domain was susceptible to trypsin digestion even at 30°C. The chains bearing the point mutationwere poorly secreted and short‐term pulse experiments showed that the extensive intracellular retention of mutant trimers also imparied the secretion of mormal chains.The molecular defect was localized in a COL1A1 allele by cloning and sequencing a cDNA region corresponding to the CB6 peptide. A G to C transversion which causes the substitution in the triple helical region of Gly910 with alanine was found. The mutation also causes the disappearance of a MspI‐recognition site at nucleotide 3263 of the proα1(I) coding sequence. Restriction analysis, along with the biochemical screening of collagens, allowed us to perform prenatal diagnosis on cells from chorionic‐villus sampling and to exclude the recurrence of the mutation in the sibling.This publication has 23 references indexed in Scilit:
- Nuclear magnetic resonance and circular dichroism studies of a triple-helical peptide with a glycine substitutionJournal of Molecular Biology, 1992
- Osteogenesis imperfecta: translation of mutation to phenotype.Journal of Medical Genetics, 1991
- Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfectaJournal of Inherited Metabolic Disease, 1990
- A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.Journal of Clinical Investigation, 1989
- Osteogenesis Imperfecta Nosology and GeneticsAnnals of the New York Academy of Sciences, 1988
- Influence of different tripeptides on the stability of the collagen triple helix. I. Analysis of the collagen sequence and identification of typical tripeptidesBiopolymers, 1986
- “In Vitro” Fibril Formation of type I Collagen from Different Sources: Biochemical and Morphological AspectsConnective Tissue Research, 1986
- Nucleotide sequences of complementary deoxyribonucleic acids for the pro.alpha.1 chain of human type I procollagen. Statistical evaluation of structures that are conserved during evolutionBiochemistry, 1983
- Structure of a cDNA for the pro.alpha.2 chain of human type I procollagen. Comparison with chick cDNA for pro.alpha.2(I) identifies structurally conserved features of the protein and the geneBiochemistry, 1983
- Proteolytic enzymes as probes for the triple-helical conformation of procollagenAnalytical Biochemistry, 1981